Baker McKenzie BV/SRL‘s competition team is a key port of call on complex multi-jurisdictional merger control matters, competition litigation and antitrust compliance. The team is particularly proficient in cartel investigation mandates, with a notable track-record in the fashion, chemicals and consumer goods sectors. Practice head Fiona Carlin specialises in merger control and State aid matters. Kurt Haegeman stands out in antitrust investigation defence, and Bram Hoorelbeke is regularly instructed for his EU State aid expertise. The three co-head the practice.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Outstanding ability to apply legal rules to in concrete business situations.’
- ‘Highly knowledgeable and attentive to actual needs.’
Key clients
- Abbott Laboratories
- AbbVie/Allergan
- ACG Inc
- adidas (U.K.) Limited
- Allegion
- Allianz
- Alpha Theta Corporation
- Arbonia
- ArcelorMittal
- Archer Daniels Midland
- Arconic
- AT&T
Work highlights
Advised Novozymes on its €1.5bn acquisition and carve out of the Animal Feed Enzymes business from dsm-Firmenich.
Advising Methanex on the antitrust aspects of its $2.05bn acquisition of OCI Global’s methanol business.
Advising Vandemoortele on merger control, Foreign Subsidies Regulation, and Foreign Direct Investment aspects in relation to its proposed acquisition of Délifrance for a consideration of €700m.
Practice head
Fiona Carlin
Other key lawyers
Kurt Haegeman; Bram Hoorelbeke